A 52-year-old man with a prosthetic aortic valve (mechanical, inserted 3 years ago for aortic stenosis) presents with fever, malaise, and new-onset heart failure. He has been compliant with anticoagulation (INR 2.5–3.5). On examination: temperature 39.2°C, new early diastolic murmur at the left sternal border, and signs of acute pulmonary edema. Blood cultures (before antibiotics) are pending. Transthoracic echocardiography is suboptimal due to acoustic shadowing from the prosthesis. Transesophageal echocardiography shows a 6 mm vegetation at the prosthetic valve-tissue interface with paravalvular aortic regurgitation. What is the most appropriate next step in management?

Explanation

## Management of Prosthetic Valve Infective Endocarditis **Key Point:** Prosthetic valve IE (PVE) is a surgical emergency. Early aggressive antibiotic therapy combined with urgent surgical evaluation is mandatory, even before culture results return. ### Why This Is Urgent **High-Yield:** Prosthetic valve endocarditis has a much worse prognosis than native valve IE: - **Early PVE** (≤1 year post-implant): Often caused by skin flora (Staphylococcus epidermidis, S. aureus) or gram-negative organisms; high risk of valve dehiscence and paravalvular abscess - **Late PVE** (>1 year post-implant): More similar to native valve IE but still carries higher mortality (20–40% vs. 15–20% for native valve IE) - **Complications:** Paravalvular abscess, valve dehiscence, acute severe regurgitation, cardiogenic shock, septic emboli ### Diagnostic Findings in This Case - **Transesophageal echocardiography (TEE)** shows vegetation at the prosthetic valve-tissue interface (pathognomonic for PVE) - **Paravalvular aortic regurgitation** indicates valve dysfunction and abscess formation - **Clinical signs of acute heart failure** suggest hemodynamic compromise ### Empiric Antibiotic Regimen for Prosthetic Valve IE **Mnemonic — VGR (Vancomycin, Gentamicin, Rifampicin):** | Drug | Dose | Rationale | |------|------|----------| | Vancomycin | 15–20 mg/kg IV Q8–12H | Covers MRSA, streptococci, enterococci | | Gentamicin | 3 mg/kg IV Q8H | Synergy against gram-positives; covers gram-negatives | | Rifampicin | 600 mg IV/PO Q6–8H | Excellent bioavailability in biofilm; covers staphylococci | **Clinical Pearl:** Do NOT wait for culture results before starting antibiotics in prosthetic valve IE. Blood cultures may take 48–72 hours; delaying therapy increases mortality and risk of irreversible valve damage. ### Surgical Indications in PVE **Urgent surgery (within 24–48 hours) is indicated for:** 1. Paravalvular abscess or fistula (as in this case) 2. Prosthetic valve dehiscence or dysfunction 3. Acute severe regurgitation with hemodynamic instability 4. Recurrent septic emboli despite antibiotics 5. Fungal endocarditis 6. Large vegetations (>10 mm) with high embolic risk This patient has **paravalvular aortic regurgitation** and **acute pulmonary edema**, which are indications for urgent surgery. ### Algorithm for PVE Management ```mermaid flowchart TD A[Suspected Prosthetic Valve IE]:::outcome --> B[Blood cultures x2 before antibiotics]:::action B --> C[TEE for vegetation, abscess, regurgitation]:::action C --> D{Complications present?}:::decision D -->|Abscess, dehiscence, severe regurgitation, shock| E[Start empiric VGR + URGENT surgery consult]:::urgent D -->|No complications, stable| F[Start empiric VGR + Early surgery consult]:::action E --> G[Intraoperative cultures + valve replacement/repair]:::action F --> G G --> H[Continue antibiotics 6 weeks post-op]:::action ``` **High-Yield:** Even with optimal antibiotics, PVE requires surgery in >50% of cases. Medical therapy alone has unacceptably high mortality (>80%). [cite:Harrison 21e Ch 137]